Published in Biotech Law Weekly, July 2nd, 2004
This condition "is thought to result from the action of streptococcus-induced antibodies that cross react with basal ganglia antigens," scientists in Brazil explained. "Much less is known, however, about the involvement of cellular mechanisms in its pathogenesis."
"Since chemokines seem to play a role in several CNS inflammatory disorders," A.L. Teixeira and colleagues at the Federal University of Minas Gerais "sought to investigate the chemokine profile of patients with SC."
"Increased serum levels of CXCL9, formerly monokine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.